Efficacy and Safety of PD-1 Inhibitor Plus Rituximab in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Qin, Yan [1 ]
He, Xiaohui [1 ]
Yang, Sheng [1 ]
Liu, Peng [1 ]
Zhou, Shengyu [1 ]
Yang, Jianliang [1 ]
Gui, Lin [1 ]
Zhong, Qiaofeng [1 ]
Zhao, Fengyi [1 ]
Shi, Yuankai [1 ]
Jing, Hongmei [2 ]
Zhang, Shiyue [3 ]
Guo, Ruihan [3 ]
Shi, Yuankai [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] Peking Univ Third Hosp, Dept Hematol, Beijing, Peoples R China
[3] Shanghai Junshi Biosci, Shanghai, Peoples R China
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-152094
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2485
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Dickinson, Michael J.
    Carlo-Stella, Carmelo
    Morschhauser, Franck
    Bachy, Emmanuel
    Corradini, Paolo
    Iacoboni, Gloria
    Khan, Cyrus
    Wrobel, Tomasz
    Offner, Fritz
    Wu, Shang-Ju
    Cartron, Guillaume
    Hertzberg, Mark
    Sureda, Anna
    Perez-Callejo, David
    Lundberg, Linda
    Relf, James
    Dixon, Mark
    Clark, Emma
    Humphrey, Kathryn
    Hutchings, Martin
    Trney, Marek
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (24): : 2220 - 2231
  • [42] BENDAMUSTINE COMBINED WITH RITUXIMAB IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: A RETROSPECTIVE MONOCENTRIC ANALYSIS
    Quirini, F.
    Pellegrini, C.
    Broccoli, A.
    Stefoni, V.
    Derenzini, E.
    Gandolfi, L.
    Casadei, B.
    Tonialini, L.
    Morigi, A.
    Celli, M.
    Argnani, L.
    Cavo, M.
    Zinzani, P. L.
    HAEMATOLOGICA, 2015, 100 : 91 - 92
  • [43] Use of gemcitabine, cisplatin and methylprednisolone with or without rituximab in relapsed and refractory patients with diffuse large B-cell lymphoma
    Sirohi, B
    Cunningham, D
    Norman, A
    Trumper, M
    Prior, Y
    Last, K
    Chong, G
    Horwich, A
    Wotherspoon, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S240 - S240
  • [44] Tisagenlecleucel and Lisocabtagene Maraleucel: Comparative Efficacy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Schuster, Stephen J.
    Zhang, Jie
    Yang, Hongbo
    Agarwal, Abhijit
    Tang, Wenxi
    Prieto, Marcela Martinez
    Bollu, Vamsi
    Kuzan, David
    Maziarz, Richard
    Kersten, Marie Jose
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S380 - S381
  • [45] Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis
    Jung Yong Hong
    Dok Hyun Yoon
    Cheolwon Suh
    Won Seog Kim
    Seok Jin Kim
    Jae-Cheol Jo
    Jin Seok Kim
    Won-Sik Lee
    Sung Yong Oh
    Yong Park
    Sung-Yong Kim
    Mark Hong Lee
    Ho Sup Lee
    Young Rok Do
    Annals of Hematology, 2018, 97 : 1437 - 1443
  • [46] Efficacy and Safety of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Caimi, Paolo F.
    Ai, Weiyun Z.
    Alderuccio, Juan Pablo
    Ardeshna, Kirit M.
    Hamadani, Mehdi
    Hess, Brian T.
    Kahl, Brad S.
    Radford, John A.
    Solh, Melhem
    Stathis, Anastasios
    Zinzani, Pier Luigi
    Feingold, Jay
    Ungar, David
    Qin, Yajuan
    He, Shui
    Carlo-Stella, Carmelo
    BLOOD, 2020, 136
  • [47] Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis
    Hong, Jung Yong
    Yoon, Dok Hyun
    Suh, Cheolwon
    Kim, Won Seog
    Kim, Seok Jin
    Jo, Jae-Cheol
    Kim, Jin Seok
    Lee, Won-Sik
    Oh, Sung Yong
    Park, Yong
    Kim, Sung-Yong
    Lee, Mark Hong
    Lee, Ho Sup
    Do, Young Rok
    ANNALS OF HEMATOLOGY, 2018, 97 (08) : 1437 - 1443
  • [48] Pembrolizumab with Rituximab in Relapsed/Refractory Follicular Lymphoma and Diffuse Large B Cell Lymphoma
    Ho, Carrie I.
    Gopal, Ajay K.
    Ujjani, Chaitra S.
    Lynch, Ryan C.
    Poh, Christina
    Voutsinas, Jenna M.
    Wu, Qian
    Vandermeer, Jacquelin
    Fromm, Jonathan R.
    Smith, Stephen D.
    BLOOD, 2023, 142
  • [49] Efficacy and Safety of Modified Rituximab-ESHAP Therapy for Relapsed/Refractory B-Cell Lymphoma
    Ueda, K.
    Nannya, Y.
    Asai, T.
    Yamamoto, G.
    Hangaishi, A.
    Takahashi, T.
    Imai, Y.
    Kurokawa, M.
    JOURNAL OF CHEMOTHERAPY, 2010, 22 (01) : 54 - 57
  • [50] Polatuzumab Vedotin in Combination with Bendamustine Plus Rituximab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Our Experience
    Darcin, Tahir
    Yigenoglu, Tugce Nur
    Sahin, Derya
    Bakirtas, Mehmet
    Basci, Semih
    Merdin, Alparslan
    Yildiz, Jale
    Ulu, Bahar Uncu
    Tetik, Aysegul
    Iskender, Dicle
    Cakar, Merih Kizil
    Dal, Mehmet Sinan
    Altuntas, Fevzi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S249 - S250
12345